Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1998
04/01/1998EP0832272A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832270A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
04/01/1998EP0832252A1 Use of gram-positive bacteria to express recombinant proteins
04/01/1998EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
04/01/1998EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus
04/01/1998EP0832241A1 Mutants of streptococcal toxin a and methods of use
04/01/1998EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family
04/01/1998EP0832237A1 Isospora suis vaccine
04/01/1998EP0832236A1 Methods for enhancement of protective immune responses
04/01/1998EP0832233A1 Human chemokine beta-13
04/01/1998EP0832232A1 Kunitz type plasma kallikrein inhibitors
04/01/1998EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
04/01/1998EP0832229A2 Cd40l mutein
04/01/1998EP0832228A1 Modified hemoglobin-like compounds and methods of purifying same
04/01/1998EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
04/01/1998EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells
04/01/1998EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof
04/01/1998EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
04/01/1998EP0832222A2 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions
04/01/1998EP0832221A1 Bone stimulating factor
04/01/1998EP0832220A1 Ob protein compositions and method
04/01/1998EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use
04/01/1998EP0832217A1 Modified steroid hormones for gene therapy and methods for their use
04/01/1998EP0832216A1 Fibroblast growth factor 15
04/01/1998EP0832215A1 Fibroblast growth factor 11
04/01/1998EP0832214A2 Oligonucleotides specific for human papillomavirus
04/01/1998EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
04/01/1998EP0832204A1 Treatment of insulin resistance
04/01/1998EP0832203A1 Use of neuro-derived fetal cell lines for transplantation therapy
04/01/1998EP0832198A1 Oxygen activatable formulations for disinfection or sterilization
04/01/1998EP0832196A1 Immortalization and disimmortalization of cells
04/01/1998EP0832190A1 Essential oligonucleotides of vertebrate telomerase
04/01/1998EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture
04/01/1998EP0832186A1 Replacement therapy for dental caries
04/01/1998EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
04/01/1998EP0832134A1 Anti-allergy bispecific molecules
04/01/1998EP0832132A1 Lymphocyte chemoattractant factor and uses thereof
04/01/1998EP0832130A1 Separation of hemoglobin on hydroxyapatite using hplc
04/01/1998EP0832129A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders
04/01/1998EP0832128A2 Thrombin receptor homolog
04/01/1998EP0832127A2 Synthetic peptides and pharmaceutical compositions comprising them
04/01/1998EP0832126A1 G-protein receptor htnad29
04/01/1998EP0832125A1 Human g-protein receptor hgber32
04/01/1998EP0832120A2 Anti-fungal d-amino acid histatin-based peptides
04/01/1998EP0832119A2 Anti-fungal and anti-bacterial histatin-based peptides
04/01/1998EP0832117A1 Ligand-stimulated gene expression
04/01/1998EP0832116A1 New dna molecules
04/01/1998EP0832115A1 PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES
04/01/1998EP0832112A1 Monocyte chemotactic protein-4
04/01/1998EP0832110A1 Antiviral peptoid compounds
04/01/1998EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use
04/01/1998EP0832106A2 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
04/01/1998EP0832105A1 Immunogenic peptides of prostate specific antigen
04/01/1998EP0832104A1 Novel dolastatin derivatives, their preparation and use
04/01/1998EP0832102A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
04/01/1998EP0832101A2 Urethane mediated, gst specific molecular release systems
04/01/1998EP0832099A1 Reversible cysteine protease inhibitors
04/01/1998EP0832098A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
04/01/1998EP0832095A1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers
04/01/1998EP0832093A1 Expression of lipoproteins
04/01/1998EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals
04/01/1998EP0831939A1 Structurally determined metallo-constructs and applications
04/01/1998EP0831937A1 Immunological combination compositions and methods
04/01/1998EP0831936A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
04/01/1998EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens
04/01/1998EP0831924A1 Method of treatment for asthma
04/01/1998EP0831920A1 Novel cathepsin and methods and compositions for inhibition thereof
04/01/1998EP0831908A1 Methods of increasing cd4+ cell numbers in hiv-infected individuals
04/01/1998EP0831907A1 Method for treating molluscum contagiosum resulting from hiv infection
04/01/1998EP0831906A1 Treatment of t cell mediated autoimmune disorders
04/01/1998EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies
04/01/1998EP0831904A1 Treatment and diagnosis of prostate cancer
04/01/1998EP0831903A1 Connective tissue growth factor
04/01/1998EP0831902A1 Muscle trophic factor
04/01/1998EP0831893A1 Regulation of cytokine synthesis and release
04/01/1998EP0831891A1 Oxidant scavengers
04/01/1998EP0831890A1 Hemodilution facilitated by monitoring oxygenation status
04/01/1998EP0831889A1 Use of il-13 to induce 15-lipoxygenase
04/01/1998EP0831888A1 Methods for increasing hematopoietic cells
04/01/1998EP0831887A1 Therapy using lymphotoxin and thrombopoietin
04/01/1998EP0831886A1 Thrombopoietin compositions
04/01/1998EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent
04/01/1998EP0831884A1 Methods and compositions for healing and repair of connective tissue attachment
04/01/1998EP0831883A1 Treatment of alzheimer disease by modulation of synapsins
04/01/1998EP0831882A1 Reconstituted collagen fiber segment compositions and methods of preparation thereof
04/01/1998EP0831881A1 Method for increasing hdl cholesterol level
04/01/1998EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors
04/01/1998EP0831879A1 Method for identifying or isolating a molecule and molecules identified thereby
04/01/1998EP0831878A1 Novel peptide inhibitors of calmodulin
04/01/1998EP0831877A1 Metabolic effects of certain glutathione analogs
04/01/1998EP0831876A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831874A1 Gene therapy for myocardial ischemia
04/01/1998EP0831873A1 The treatment of hiv and other viral infections using combinatory therapy
04/01/1998EP0831872A1 Polypeptide compounds that form beta sheets
04/01/1998EP0831871A1 Relaxin-like factor and methods and uses thereof
04/01/1998EP0831870A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
04/01/1998EP0831868A1 Ocular therapy in sjögren's syndrome using topically applied androgens or tgf-beta
04/01/1998EP0831867A1 Collagen-based delivery matrix
1 ... 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 ... 3163